Top Markets
#1 GALA GALA +34.47%
#2 Magma Finance Magma Finance +32.81%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +32.48%
#4 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +30.91%
#5 Bitcoin Cash Bitcoin Cash +30.80%
#6 Talus Network Talus Network +29.71%
#7 TROLL TROLL +28.68%
#8 Useless Coin Useless Coin +28.50%
#9 Bless Bless +28.17%
#10 Ethereum Name Service Ethereum Name Service +28.00%
Coin of the day
GALA GALA
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Miromatrix Medical Inc. Miromatrix Medical Inc.

Miromatrix Medical Inc.

MIRO
Rang in Aktien #24477
Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a... Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary platform utilizing a two-stage method involving decellularization and recellularization. This sophisticated process entails meticulously removing the native porcine cells from organs harvested from pigs, then introducing unmodified human cells to create viable new structures. Miromatrix maintains significant partnerships with esteemed medical institutions such as The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company, which was originally incorporated in 2009 under the name TayTech, Inc., operates from its headquarters in Eden Prairie, Minnesota.
Aktienkurs
$3.39
Zuletzt synchronisiert: 2023-12-22
Marktkapitalisierung
$60.24M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Miromatrix Medical Inc. (MIRO)

Kategorie

Healthcare
P/B-Verhältnis für Miromatrix Medical Inc. (MIRO)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Miromatrix Medical Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Miromatrix Medical Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH